这一变化源于CDC建议仅提供一次终身剂量的疫苗,使得适用人口减少。虽然未来可能会根据长期数据调整剂量建议,但目前GSK的AREXVY™被认为最有可能占据市场主导地位。此外,Beyfortus™预计在2024年下半年表现优异,2029年全球销售额可能达12.7亿美...
controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003; 37: 1155–64.
The objective of this study was to estimate the annual population-level impact of PCV13 NIPs on vaccine-type and non-vaccine type (NVT) IPD incidence among children and adults using national surveillance data of countries that switched from PCV7 to PCV13 in their NIP. A 20-valent vaccine (...
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13 Mark H. Rozenbaum, Liping Huang, Alejandro Cane, Adriano Arguedas, Ruth Chapman, Desmond Dillon-Murphy, show all Pages...
CDC: Centre for Disease Control GAVI: Global Alliance for Vaccine Initiatives IDRL: Infectious Disease Research Laboratory IPD: Invasive Pneumococcal Disease PCR: Polymerase Chain Reaction PCV: Pneumococcal Conjugate Vaccine PCV10: 10Valent Pneumococcal Conjugate Vaccine ...
On February 24, 2010, a 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by Pfizer ... JP Nuorti,CG Whitney,Centers for Disease Control and Prevention (CDC) - 《Morbidity & Mortality Weekly Report Recommendations & Reports》...
In this study, we aimed to investigate the pneumococcal lineages behind the predominant serotypes, the mechanism of serotype replacement in disease, as well as the major pneumococcal lineages contributing to invasive pneumococcal disease in the post-vaccine era and their antibiotic resistant traits. ...
[9] 韦宁, 等. 中国疫苗和免疫. 2014;20(6):547-55. [10] https://www.cdc.gov/vaccines/pubs/surv-manual/chpt11-pneumo.html [11] Park DE, et al. Pediatr Infect Dis J. 2014. 33 Suppl 2: S130-9. [12] Madhi SA, et al. Vaccine. 2011. 29(40): 6994-7001. ...
[8] https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm [9]Hammitt LL, Akech DO, Morpeth SC, et al.The Lancet Global Health; 28 May 2014 [10]Palmu AA, et al. “Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine against invasive pneumococcal...
[9] 韦宁, 等. 中国疫苗和免疫. 2014;20(6):547-55. [10] https://www.cdc.gov/vaccines/pubs/surv-manual/chpt11-pneumo.html [11] Park DE, et al. Pediatr Infect Dis J. 2014. 33 Suppl 2: S130-9. [12] Madhi SA, et al. Vaccine. 201...